Douglas A Treco - Net Worth and Insider Trading
Douglas A Treco Net Worth
The estimated net worth of Douglas A Treco is at least $63,028 dollars as of 2024-12-26. Douglas A Treco is the CEO of Inozyme Pharma Inc and owns about 20,665 shares of Inozyme Pharma Inc (INZY) stock worth over $63,028. Details can be seen in Douglas A Treco's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas A Treco has not made any transactions after 2024-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas A Treco
Douglas A Treco Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas A Treco owns 3 companies in total, including Inozyme Pharma Inc (INZY) , CRISPR Therapeutics AG (CRSP) , and Ra Pharmaceuticals Inc (RARX) .
Click here to see the complete history of Douglas A Treco’s form 4 insider trades.
Insider Ownership Summary of Douglas A Treco
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2024-04-02 | director |
| CRSP | CRISPR Therapeutics AG | 2020-06-11 | director |
| RARX | Ra Pharmaceuticals Inc | 2020-04-02 | director & President and CEO |
Douglas A Treco Latest Holdings Summary
Douglas A Treco currently owns a total of 1 stock. Douglas A Treco owns 20,665 shares of Inozyme Pharma Inc (INZY) as of April 2, 2024, with a value of $63,028.
Latest Holdings of Douglas A Treco
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2024-04-02 | 20,665 | 3.05 | 63,028 |
Holding Weightings of Douglas A Treco
Douglas A Treco Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas A Treco has made a total of 1 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Inozyme Pharma Inc is the sale of 7,523 shares on April 2, 2024, which brought Douglas A Treco around $52,210.
Insider Trading History of Douglas A Treco
- 1
Douglas A Treco Trading Performance
Douglas A Treco Ownership Network
Douglas A Treco Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Douglas A Treco is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Douglas A Treco made 1 insider transaction in Inozyme Pharma Inc (INZY) with a net sale of 7,523. Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net purchase of 833,333 shares made by Robert Lorne Hopfner ,
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Douglas A Treco Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas A Treco. You might contact Douglas A Treco via mailing address: 87 Cambridgepark Drive, C/o Ra Pharmaceuticals, Inc., Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
